Abstract
The bioactive metabolites produced by cyanobacteria are either a peptide or macrolide structure, or a combination of both types. The peptide class is produced by two types of biosynthetic pathways: the giant multidomain enzymes, the nonribosomal peptide synthetases (NRPS) or by ribosomal synthesis and subsequent posttranslational modification and processing. The major trait of cyanobacterial pathways is their hybrid character, i.e., the frequent mixture of NRPS and polyketide synthases (PKS) modules. We discussed the important metabolites of cyanobacteria and their biosynthetic metabolic pathways. Various recent approaches in extraction of novel secondary metabolites from cyanobacteria are discussed with novel biosynthetic gene clusters found in them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agger SA, Lopez-Gallego F, Hoye TR, Schmidt-Dannert C (2008) Identification of sesquiterpene synthases from Nostoc punctiforme PCC 73102 and Nostoc sp. strain PCC 7120. J Bacteriol 190:6084
Alder A, Bigler P, Werck-Reichhart D, Al-Babili S (2009) In vitro characterization of Synechocystis CYP120A1 revealed the first non-animal retinoic acid hydroxylase. FEBS J 276:5416–5431
Bachmann BO, Ravel J (2009) In silico prediction of microbial secondary metabolic pathways from DNA sequence data. Methods Enzymol 458:181–217
Balskus EP, Walsh CT (2008) Investigating the initial steps in the biosynthesis of cyanobacterial sunscreen scytonemin. J Am Chem Soc 130:15260–15261
Balskus EP, Walsh CT (2009) An enzymatic cyclopentyl [b] indole formation involved in scytonemin biosynthesis. J Am Chem Soc 131:14648–14649
Balskus EP, Walsh CT (2010) The genetic and molecular basis for sunscreen biosynthesis in cyanobacteria. Sci 329:1653–1656
Bernhardt R (2006) Cytochromes P450 as versatile biocatalysts. J Biotechnol 124:128–145
Bok JW, Hoffmeister D, Maggio-Hall LA, Murillo R, Glasner JD, Keller NP (2006) Genomic mining for Aspergillus natural products. Chem Biol 13:31–37
Bok JW, Chiang YM, Szewczyk E, Reyes-Dominguez Y, Davidson AD, Sanchez JF, Lo HC, Watanabe K, Strauss J, Oakley BR, Wang CC, Keller NP (2009) Chromatin-level regulation of biosynthetic gene clusters. Nat Chem Biol 5:462–464
Cadel-Six S, Iteman I, Peyraud-Thomas C, Mann S, Ploux O, Méjean A (2009) Identification of a polyketide synthase coding sequence specific for anatoxin-a-producing Oscillatoria cyanobacteria. Appl environ microbiol 75:4909–4912
Campbell CD, Vederas JC (2010) Biosynthesis of lovastatin and related metabolites formed by fungal iterative PKS enzymes. Biopolymers 93:755–763
Cane DE (2010) Programming of erythromycin biosynthesis by a modular polyketide synthase. J Biol Chem 285:27517–27523
Challis GL (2008) Mining microbial genomes for new natural products and biosynthetic pathways. Microbiol 154:1555–1569
Chang Z, Flatt P, Gerwick WH, Nguyen VA, Willis CL, Sherman DH (2002) Genes encoding synthetases of cyclic depsipeptides, anabaenopeptilides, in Anabaena strain 90. Gene 296:235–247
Chughtai K, Heeren RM (2010) Mass spectrometric imaging for biomedical tissue analysis. Chem Rev 110:3237–3277
Cichewicz RH (2010) Epigenome manipulation as a pathway to new natural product scaffolds and their congeners. Nat Prod Rep 27:11–22
Comess KM, Schurdak ME (2004) Affinity-based screening techniques for enhancing lead discovery. Curr Opin Drug Discov Dev 7:411–416
Cornett DS, Reyzer ML, Chaurand P, Caprioli RM (2007) MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods 4:828–833
Cortina NS, Krug D, Plaza A, Revermann O, Müller R (2012) Myxoprincomide: a natural product from Myxococcus xanthus discovered by comprehensive analysis of the secondary metabolome. Angew Chem Int Ed 51:811–816
Davies J, Ryan KS (2012) Introducing the parvome: bioactive compounds in the microbial world. ACS Chem Biol 7:252–259
DiMasi JA, Hansen RW, Grabowsk HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151–185
Edwards PA, Ericsson J (1999) Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68:157–185
Edwards DJ, Marquez BL, Nogle LM, McPhail K, Goeger DE, Roberts MA, Gerwick WH (2004) Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chem Bio 11:817–833
Ekins S, Mestres J, Testa B (2007) In silico pharmacology of drug discovery: methods of virtual ligand screening and profiling. Br J Pharmacol 152:9–20
Erhard M, von Dohren H, Junblut P (1997) Rapid typing and elucidation of new secondary metabolites of intact cyanobacteria using MALDI-TOF mass spectrometry. Nat Biotechnol 15:906–909
Esquenazi E, Coates C, Simmons L, Gonzalez D, Gerwick WH, Dorrestein PC (2008) Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging. Mol Biosyst 4:562–570
Exarchou V, Krucker M, van Beek TA, Vervoort J, Gerothanassis IP, Albert K (2005) LC-NMR coupling technology: recent advancements and applications in natural products analysis. Magn Reson Chem 43:681–687
Feng Z, Kim JH, Brady SF (2010) Fluostatins produced by the heterologous expression of a TAR reassembled environmental DNA derived type II PKS gene cluster. J Am Chem Soc 132:11902–11903
Gehret JJ, Gu L, Gerwick WH, Wipf P, Sherman DH, Smith JL (2011) Terminal alkene formation by the tioesterase of curacin A biosynthesis: structure of a decarboxylating thioesterase. J Biol Chem 286:14445–14454
Gessel MM, Norris JL, Caprioli RM (2014) MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteomics 107:71–82. http://dx.doi.org/10.1016/j.jprot.2014.03.021
Gonzalez DJ, Xu Y, Yang YL, Esquenazi E, Liu WT, Edlund A, Duong T, Du L, Molnar I, Gerwick WH, Jensen PR, Fischbach M, Liaw CC, Straight P, Nizet V, Dorrestein PC (2012) Observing the invisible through imaging mass spectrometry, a window into the metabolic exchange patterns of microbes. J Prot 75:5069–5076
Grata E, Boccard J, Guillarme D, Glauser G, Carrupt PA, Framer EE, wolfender JL, Rudaz S (2008) UPLC-TOF-MS for plant metabolomics: a sequential approach for wound marker analysis in Arabidopsis thaliana. J Chromatogr B 871:261–270
Grindberg RV, Ishoey T, Brinza D, Esquenazi E, Coates RC, Liu WT, Gerwick L, Dorrestein PC, Pevzner P, Lasken R, Gerwick WH (2011) Single cell genome amplification accelerates identification of the apratoxin biosynthetic pathway from a complex microbial assemblage. PLoS ONE 6:e18565
Gross H (2009) Genomic mining-a concept for the discovery of new bioactive natural products. Curr Opin Drug Discov Devel 12:207–219
Grünewald J, Marahiel MA (2006) Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides. Microbiol Mol Biol Rev 70:121–146
Guiochon G, Tarafder A (2011) Fundamental challenges and opportunities for preparative supercritical fluid chromatography. J Chromatogr A 1218:1037–1114
Hasan RH, Sorkhoh NA, Bader D, Radwan SS (1994) Utilization of hydrocarbons by cyanobacteria from microbial mats on oily coasts of the Gulf. Appl Microbiol Biotechnol 41:615–619
Herrero A, Flores E (2008) The cyanobacteria. Horizon Scientific, Norfolk, pp 484
Hertweck C (2009) Hidden biosynthetic treasures brought to light. Nat Chem Biol 5:450–452
Hess WR (2011) Cyanobacterial genomics for ecology and biotechnology. Curr Opin Microbiol 14:608–614
Hoffmann D, Hevel JM, Moore RE, Moore BS (2003) Sequence analysis and biochemical characterization of the nostopeptolide A biosynthetic gene cluster from Nostoc sp. GSV224. Gene 311:171–180
Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730
Jenke-Kodama H, Sandmann A, Müller R, Dittmann E (2005) Evolutionary implications of bacterial polyketide synthases. Mol Biol Evol 22:2027–2039
Ke N, Baudry J, Makris TM, Schuler MA, Sligar SG (2005) A retinoic acid binding cytochrome P450: CYP120A1 from Synechocystis sp. PCC 6803. Arch Biochem Biophys 436:110–120
Kramer R, Cohen D (2004) Functional genomics to new drug targets. Nat Rev Drug Discov 3:965–972
Kroemer RT (2007) Structure-based drug design: docking and scoring. Curr Protein Pept Sci 8:312–328
Kühnel K, Ke N, Cryle MJ, Sligar SG, Schuler MA, Schlichting I (2008) Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. Biochemistry 47:6552–6559
Kuhnert N, Jaiswal R, Eravuchira P, El-Abassy RM, von der KB, Materny A (2011) Scope and limitations of principal component analysis of high resolution LC-TOF-MS data: the analysis of the chlorogenic acid fraction in green coffee beans as a case study. Anal Methods 3:144–155
Lee I, Oh JH, Shwab EK, Dagenais TR, Andes D, Keller NP (2009) HdaA, a class 2 histone deacetylase of Aspergillus fumigatus, affects germination and secondary metabolite production. Fungal Genet Biol 46:782–790
Liu WT, Yang YL, Xu Y, Lamsa A, Haste NM, Yang JY, Ng J, Gonzalez D, Ellermeier CD, Straight PD, Pevzner PA, Pogliano J, Nizet V, Pogliano K, Dorrestein PC (2010) Imaging mass spectrometry of intra species metabolic exchange revealed the cannibalistic factors of Bacillus subtilis. Proc Natl Acad Sci U S A 107:16286–16290
McIntosh JA, Donia MS, Schmidt EW (2010) Insights into heterocyclization from two highly similar enzymes. J Am Chem Soc 132:4089–4091
Mejean A, Mann S, Maldiney T, Vassiliadis G, Lequin O, Ploux O (2009) Evidence that biosynthesis of the neurotoxic alkaloids anatoxin-a and homoanatoxin-a in the cyanobacterium Oscillatoria PCC 6506 occurs on a modular polyketide synthase initiated by L-proline. J Am Chem Soc 131:7512
Moffitt MC, Neilan BA (2004) Characterization of the nodularin synthetase gene cluster and proposed theory of the evolution of cyanobacterial hepatotoxins. Appl Environ Microbiol 70:6353–6362
Molinski TF (2010) NMR of natural products at the ‘nanomole-scale’. Nat Prod Rep 27:321–329
Nebert DW, Nelson DR, Feyereisen R (1989) Evolution of the cytochrome P450 genes. Xenobiotica 19:1149–1160
Oman TJ, van der Donk WA (2010) Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol 6:9–18
Onyango P (2004) The role of emerging genomics and proteomics technologies in cancer drug target discovery. Curr Cancer Drug Targets 4:111–124
Pearson L, Mihali T, Moffitt M, Kellmann R, Neilan B (2010) On the chemistry, toxicology and genetics of the cyanobacterial toxins, microcystin, nodularin, saxitoxin and cylindrospermopsin. Marine Drugs 8:1650–1680
Philmus B, Guerrette JP, Hemscheidt TK (2009) Substrate specificity and scope of MvdD, a GRASP-like ligase from the microviridin biosynthetic gene cluster. ACS Chem Biol 4:429–434
Piel J (2010) Biosynthesis of lovastatin and related metabolites formed by fungal iterative PKS enzymes. Nat Prod Rep 27:996–1047
Rajamani R, Good AC (2007) Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development’. Curr Opin Drug Discov Devel 10:308–315
Rouhiainen L, Paulin L, Suomalainen S, Hyytiainen H, Buikema W, Haselkorn R, Sivonen K (2000) Genes encoding synthetases of cyclic depsipeptides, anabaenopeptilides, in Anabaena strain 90. Mol Microbiol 37:156–167
Sangeetha M, Menakha M, Vijayakumar S (2014) Cryptophycin F-A potential cyanobacterial drug for breast cancer Biomed Aging Path. 4:229–234
Schley C, Altmeyer MO, Swart R, M¨uller R, Huber CG (2006) Proteome analysis of Myxococcus xanthus by off-line two-dimensional chromatographic separation using monolithic poly-(styrene-divinylbenzene) columns combined with ion-trap tandem mass spectrometry. J Proteome Res 5:2760–2768
Schmidt EW, Nelson JT, Rasko DA, Sudek S, Eisen JA, Haygood MG, Ravel J (2005) Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc Natl Acad Sci U S A 102:7315–7320
Schmitt EK, Moore CM, Krastel P, Petersen F (2011). Natural products as catalysts for innovation: a pharmaceutical industry perspective. Curr Opin Chem Biol 15:497–504 (Excerpts used with permission)
Schroder FC, Farmer JJ, Attygalle AB, Smedley SR, Eisner T, Meinwald J (1998) Combinatorial chemistry in insects: a library of defensive macrocyclic polyamines. Sci 281:428–431
Schwarzer D, Finking R, Marahiel MA (2003) Nonribosomal peptides: from genes to products. Nat Prod Rep 20:275–287
Seeley EH, Caprioli RM (2008) Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci U S A 105:18126–18131
Shalev‐Malul G, Lieman‐Hurwitz J, Viner‐Mozzini Y, Sukenik A, Gaathon A, Lebendiker M, Kaplan A (2008) An AbrB‐like protein might be involved in the regulation of cylindrospermopsin production by Aphanizomenon ovalisporum. Environ Microbiol 10:988–999
Shanta SR, Zhou LH, Park YS, Kim YH, Kim Y, Kim KP (2012) Binary matrix for MALDI imaging mass spectrometry of phospholipids in both ion modes. Anal Chem 83:1252–1259
Shastri AA, Morgan JA (2005) Flux balance analysis of photoautotrophic metabolism. Biotechnol Prog 21:1617–1626
Singh S, Verma SK (2012) Application of direct analysis in real time mass spectrometry (DART-MS) for identification of an epiphytic cyanobacterium, Nostoc sp. Anal Lett 45:2562–2568
Soule T, Stout V, Swingley WD, Meeks JC, Garcia-Pichel F (2007) Molecular genetics and genomic analysis of scytonemin biosynthesis in Nostoc punctiforme ATCC 29133. J Bacteriol 189:4465–4472
Staunton J, Weissman K (2001) Polyketide biosynthesis: a millennium review. J Nat Prod Rep 18:380–416
Szewczyk E, Chiang YM, Oakley CE, Davidson AD, Wang CC, Oakley BR (2008) Identification and characterization of the asperthecin gene cluster of Aspergillus nidulans. Appl Environ Microbiol 74:7607–7612
Thomason L, Court DL, Bubunenko M, Costantino N, Wilson H, Datta S, Oppenheim A (2007) Recombineering: genetic engineering in bacteria using homologous recombination. Curr Protoc Mol Biol. doi:10.1002/0471142727.mb0116s106 (Chap. 1: Unit 1.16)
Tillett D, Dittmann E, Erhard M, von Döhren H, Börner T, Neilan BA (2000) Structural organization of microcystin biosynthesis in Microcystis aeruginosa PCC7806: an integrated peptide-polyketide synthetase system. Chem Biol 7:753–764
Torres S, Fjetland CR, Lammers PJ (2005) Alkane-induced expression, substrate binding profile, and immunolocalization of a cytochrome P450 encoded on the nifD excision element of Anabaena 7120. BMC Microbiol 5:1–12
Velasquez JE, van der Donk WA (2011) Genome mining for ribosomal synthesized natural products. Curr Opin Chem Biol 15:11–21
Vijayakumar S, Menakha M (2013) Tasiamide-B a new cyanobacterial compound for treating skin cancer. Biomed Prev Nutr 4:355–358. http://dx.doi.org/10.1016/j.bionut.2013.10.001
Vijayakumar S, Menakha M (2014) Prediction of new cyanobacterial drug for treating lung cancer. Biomed Aging Patho 4:49–52
Walsh CT, Fischbach MA (2010) Natural products version 2.0: connecting genes to molecules. J Am Chem Soc 132:2469–2493
Weber T (2014) In silico tools for the analysis of antibiotic biosynthetic pathways. Int J of Med Microbiol 304:230-235 (Excerpt used with permission)
Welker M, Von Döhren H (2006) Cyanobacterial peptides-nature’s own combinatorial biosynthesis. FEMS Microbiol Rev 30:530–563
Welker M, Marsalek B, Sejnohova L, von Dohren H (2006) Detection and identification of oligopeptides in Microcystis (cyanobacteria) colonies: toward an understanding of metabolic diversity. Peptides 27:2090–2103
Wolfender JL, Marti G, Queiroz EF (2010) Advances in techniques for profiling crude extracts and for the rapid identification of natural products: dereplication, quality control and metabolomics. Curr Org Chem 14:1808–1832
Xu Y, Alvey RM, Byrne PO, Graham JE, Shen G, Bryant DA (2011) Expression of genes in cyanobacteria: adaptation of endogenous plasmids as platforms for high-level gene expression in Synechococcus sp. PCC 7002. Methods Mol Biol 684:273–293
Yang YL, Xu YQ, Straight P, Dorrestein PC (2009) Translating metabolic exchange with imaging mass spectrometry. Nat Chem Biol 5:885–887
Ziemert N, Ishida K, Liaimer A, Hertweck C, Dittmann E (2008) Ribosomal synthesis of tricyclic depsipeptides in bloom-forming cyanobacteria. Angew Chem Int Ed Engl 47:7756–7759
Ziemert N, Ishida K, Weiz A, Hertweck C, Dittmann E (2010) Exploiting the natural diversity of microviridin gene clusters for discovery of novel tricyclic depsipeptides. Appl Env Microbiol 76:3568–3574
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mandal, S., Rath, J. (2015). Secondary Metabolites of Cyanobacteria and Drug Development. In: Extremophilic Cyanobacteria For Novel Drug Development. SpringerBriefs in Pharmaceutical Science & Drug Development. Springer, Cham. https://doi.org/10.1007/978-3-319-12009-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-12009-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12008-9
Online ISBN: 978-3-319-12009-6
eBook Packages: MedicineMedicine (R0)